In GBM, mRNA expression of FLT3 and its natural ligand FLT3L is detected in astrocytic tumors as well as GBM cell lines [124]; however, the exact mechanism by which FLT3 contributes to GBM occurrence/progression remains unknown. This evidence concerns the gene FLT3 and glioblastoma.